Most Recent
Fiducian Investment Management has copped a $7.3 million penalty after admitting that it made misleading representations about the ESG credentials of an investment fund, despite senior execs being warned about its exposure to fossil fuels.
Two Deloitte reports commissioned by a Swiss law firm for Credit Suisse are protected by legal professional privilege despite access given to financial regulators investigating the collapse of supply chain financier Greensill.
Credit Suisse is fighting a bid for access to Deloitte reports commissioned by a Swiss law firm and advice from Linklaters, in litigation against insurers over the collapse of supply chain finance company Greensill Capital.
US-based advisory firm White Oak, which has sued insurer IAL over the collapse of Greensill Capital, has been ordered to hand over WhatsApp messages between its former CEO and billionaire Sanjeev Gupta.
Insurers Marsh Limited and Insurance Australia Limited are seeking production of two reports by Deloitte commissioned by a Swiss law firm in litigation over the collapse of supply chain finance company Greensill Capital.
ASIC has lost its case alleging software company Nuix failed to publish corrective disclosures that contradicted the growth story presented to the market in a prospectus for its $1.8 billion float on the ASX.
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.